Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cisapride poisoning |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Accidental cisapride poisoning |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
Intentional cisapride poisoning |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
intoxication par la cisapride d'intention indéterminée |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride adverse reaction |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Allergy to cisapride |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
Cisapride overdose |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Accidental cisapride overdose |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Intentional cisapride overdose |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
surdose de cisapride d'intention indéterminée |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Product containing cisapride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
Cisapride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
Cisapride 1mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
Accidental cisapride poisoning |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Intentional cisapride poisoning |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Allergy to cisapride |
Causative agent (attribute) |
False |
Cisapride (substance) |
Inferred relationship |
Some |
2 |
Cisapride monohydrate (substance) |
Is a |
False |
Cisapride (substance) |
Inferred relationship |
Some |
|
Cisapride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Product containing cisapride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cisapride (substance) |
Inferred relationship |
Some |
|
Product containing only cisapride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Product containing only cisapride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Allergy to cisapride |
Causative agent (attribute) |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride 1 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |
Cisapride 1 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cisapride (substance) |
Inferred relationship |
Some |
1 |